Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 1;106(7):e343-e345.
doi: 10.1097/TP.0000000000004150. Epub 2022 Mar 24.

Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience

Biagio Pinchera  1 , Antonio Riccardo Buonomo  1 , Riccardo Scotto  1 , Rosa Carrano  2 , Fabrizio Salemi  2 , Fabiana Galluccio  2 , Maria Guarino  3 , Giulio Viceconte  1 , Nicola Schiano Moriello  1 , Agnese Giaccone  1 , Antonella Gallicchio  1 , Emanuela Zappulo  1 , Riccardo Villari  1 , Ivan Gentile  1 ; Federico II COVID team
Affiliations

Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience

Biagio Pinchera et al. Transplantation. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no funding and conflicts of interest.

References

    1. Gentile I, Maraolo AE, Buonomo AR, et al. . Monoclonal antibodies against SARS-CoV-2: potential game-changer still underused. Int J Environ Res Public Health. 2021;18:11159. - PMC - PubMed
    1. Yetmar ZA, Beam E, O’Horo JC, et al. . Monoclonal antibody therapy for COVID-19 in solid organ transplant recipients. Open Forum Infect Dis. 2021;8:ofab255. - PMC - PubMed
    1. Dhand A, Lobo SA, Wolfe K, et al. . Casirivimab-imdevimab for treatment of COVID-19 in solid organ transplant recipients: an early experience. Transplantation. 2021;105:e68–e69. - PubMed
    1. Fernandes G, Devresse A, Scohy A, et al. . Monoclonal antibody therapy for SARS-CoV-2 infection in kidney transplant recipients: a case series from Belgium. Transplantation. 2022;106:e107–e108. - PMC - PubMed
    1. WHO R&D Blueprint. COVID-19 therapeutic trial synopsis. World Health Organization; 2020:1–12.